Metabolic Adaptation-Mediated Cancer Survival and Progression in Oxidative Stress

Yongquan Tang1,2, Zhe Zhang2, Yan Chen2

  • 1Department of Pediatric Surgery, West China Hospital, Sichuan University, Chengdu 610041, China.

Insights

Cancer cells adapt to oxidative stress via metabolic reprogramming, utilizing NADPH and GSH for ROS scavenging. Understanding these adaptations is key for developing new cancer therapies.

Area of Science:

  • Oncology
  • Metabolic pathways
  • Cellular stress response

Background:

  • Elevated reactive oxygen species (ROS) levels are common in cancer evolution, driven by therapies and immune responses.
  • High ROS can induce cancer cell death by disrupting glycolysis and oxidative phosphorylation (OXPHOS).
  • Cancer cells exhibit metabolic reprogramming to survive oxidative and metabolic stress, leading to residual disease and relapse.

Purpose of the Study:

  • To summarize mechanisms of metabolic regulation in cancer cell adaptation to oxidative stress.
  • To review the role of metabolic adaptations in cancer survival and progression.
  • To highlight opportunities for therapeutic intervention by manipulating cancer cell metabolism.

Main Methods:

  • Literature review of studies on cancer cell metabolism and oxidative stress.
  • Analysis of metabolic reprogramming strategies employed by cancer cells.
  • Synthesis of current understanding of ROS-scavenging pathways (NADPH, GSH) and metabolic shifts (lipolysis, glutaminolysis).

Main Results:

  • Cancer cells adapt to ROS-induced metabolic disruption through reprogramming.
  • Key adaptations include NADPH and GSH synthesis for ROS scavenging.
  • Upregulation of lipolysis and glutaminolysis supports OXPHOS and biosynthesis, fueling cancer progression.

Conclusions:

  • Metabolic reprogramming is crucial for cancer cell survival under oxidative stress.
  • Understanding these adaptive mechanisms offers therapeutic targets for cancer prevention and treatment.
  • Further research into the underlying mechanisms can guide novel anti-cancer strategies.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
14.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
437
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.9K